• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 - 2023年204个国家和地区心血管疾病及风险因素的全球、区域和国家负担

Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023.

出版信息

J Am Coll Cardiol. 2025 Dec 2;86(22):2167-2243. doi: 10.1016/j.jacc.2025.08.015. Epub 2025 Sep 24.

DOI:10.1016/j.jacc.2025.08.015
PMID:40990886
Abstract

BACKGROUND

Cardiovascular diseases (CVDs) are the leading cause of mortality and are among the foremost causes of disability globally. CVD burden has continued to increase in most countries since 1990, with trends driven by changing exposures to harmful risk factors, population growth, and population aging.

OBJECTIVES

We report estimates of global, national, and subnational CVD burden, including 18 subdiseases and 12 associated modifiable risk factors. We analyzed change in CVD burden from 1990 to 2023 and identified drivers of change including population growth, population aging, and risk factor exposure.

METHODS

The Global Burden of Disease (GBD) 2023 study, a multinational collaborative research study, quantified burden due to 375 diseases including CVD burden and identified drivers of change from 1990 to 2023 using all available data and statistical models. GBD 2023 estimated the population-level burden of diseases in 204 countries and territories from 1990 to 2023.

RESULTS

CVDs were the leading cause of disability-adjusted life years (DALYs) and deaths estimated in the GBD. As of 2023, there were 437 million (95% UI: 401 to 465 million) CVD DALYs globally, a 1.4-fold increase from the number in 1990 of 320 million (292 to 344 million). Ischemic heart disease, intracerebral hemorrhage, ischemic stroke, and hypertensive heart disease were the leading cardiovascular causes of DALYs in 2023 globally. As of 2023, age-standardized CVD DALY rates were highest in low and low-middle Socio-demographic Index (SDI) settings and lowest in high SDI settings. The number of CVD deaths increased globally from 13.1 million (95% UI: 12.2 to 14.0 million) in 1990 to 19.2 million (95% UI: 17.4 to 20.4 million) in 2023. The number of prevalent cases of CVD more than doubled since 1990, with 311 million (95% UI: 294 to 333 million) prevalent cases of CVD in 1990 and 626 million (95% UI: 591 to 672 million) prevalent cases in 2023 globally. A total of 79.6% (95% UI: 75.7% to 82.5%) of CVD burden is attributable to modifiable risk factors 347 million [95% UI: 318 to 373 million] DALYs in 2023). Globally, high systolic blood pressure, dietary risks, high low-density lipoprotein cholesterol, and air pollution were the modifiable risks responsible for most attributable CVD burden in 2023. Since 1990, changes in exposure to modifiable risk factors have had mixed effects on CVD burden, with increases in high body mass index, high fasting plasma glucose, and low physical activity leading to higher burden, while reductions in tobacco usage have mitigated some of these increases. Population growth and population aging were the main drivers of the increasing burden since 1990, adding 128 million (95% UI: 115 to 139 million) and 139 million (95% UI: 126 to 151 million) CVD DALYs to the increase in CVD burden since 1990.

CONCLUSIONS

CVD remains the leading cause of disease burden and death worldwide with the greatest burden in low, low-middle, and middle SDI regions. Large variation exists in CVD burden even for countries at similar levels of development, a gap explained substantially by known, modifiable risk factors that are inadequately controlled. The decades-long increase in CVD burden was the result of population growth, population aging, and increased exposure to a subset of risk factors led by metabolic risks. Countries will need to adopt effective health system and public health strategies if they are to progress in achieving global goals to reduce the burden of CVD.

摘要

背景

心血管疾病(CVDs)是全球主要的死亡原因,也是导致残疾的首要原因之一。自1990年以来,大多数国家的心血管疾病负担持续增加,这种趋势受到有害风险因素暴露变化、人口增长和人口老龄化的驱动。

目的

我们报告全球、国家和次国家层面心血管疾病负担的估计数据,包括18种亚疾病和12种相关的可改变风险因素。我们分析了1990年至2023年心血管疾病负担的变化,并确定了变化的驱动因素,包括人口增长、人口老龄化和风险因素暴露。

方法

全球疾病负担(GBD)2023研究是一项跨国合作研究,对包括心血管疾病负担在内的375种疾病的负担进行了量化,并利用所有可用数据和统计模型确定了1990年至2023年的变化驱动因素。GBD 2023估计了1990年至2023年204个国家和地区的人群层面疾病负担。

结果

心血管疾病是GBD中估计的伤残调整生命年(DALYs)和死亡的主要原因。截至2023年,全球有4.37亿(95%不确定区间:4.01亿至4.65亿)心血管疾病伤残调整生命年,比1990年的3.2亿(2.92亿至3.44亿)增加了1.4倍。缺血性心脏病、脑出血、缺血性中风和高血压性心脏病是2023年全球心血管疾病导致伤残调整生命年的主要原因。截至2023年,年龄标准化的心血管疾病伤残调整生命年率在社会人口指数(SDI)较低和中低水平地区最高,在高SDI地区最低。全球心血管疾病死亡人数从

相似文献

1
Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023.1990 - 2023年204个国家和地区心血管疾病及风险因素的全球、区域和国家负担
J Am Coll Cardiol. 2025 Dec 2;86(22):2167-2243. doi: 10.1016/j.jacc.2025.08.015. Epub 2025 Sep 24.
2
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.1990年至2023年期间,204个国家和地区(包括660个次国家级地区)375种疾病和损伤的负担、88种风险因素的风险归因负担以及健康预期寿命:全球疾病负担研究2023的系统分析
Lancet. 2025 Oct 18;406(10513):1873-1922. doi: 10.1016/S0140-6736(25)01637-X. Epub 2025 Oct 12.
3
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.1990 - 2023年204个国家和地区以及660个次国家级地区292种死因的全球负担:全球疾病负担研究2023的系统分析
Lancet. 2025 Oct 18;406(10513):1811-1872. doi: 10.1016/S0140-6736(25)01917-8. Epub 2025 Oct 12.
4
Burden and attributable risk factors of non-communicable diseases and subtypes in 204 countries and territories, 1990-2021: a systematic analysis for the global burden of disease study 2021.1990 - 2021年204个国家和地区非传染性疾病及其亚型的负担和可归因风险因素:全球疾病负担研究2021的系统分析
Int J Surg. 2025 Mar 1;111(3):2385-2397. doi: 10.1097/JS9.0000000000002260.
5
Global burden of vision impairment due to age-related macular degeneration, 1990-2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.1990年至2021年因年龄相关性黄斑变性导致的视力损害全球负担,以及到2050年的预测:全球疾病负担研究2021的系统分析
Lancet Glob Health. 2025 Jul;13(7):e1175-e1190. doi: 10.1016/S2214-109X(25)00143-3.
6
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.1950 - 2023年204个国家和地区以及660个次国家级地区的全球特定年龄和性别的全因死亡率及预期寿命估计:《2023年全球疾病负担研究》的人口分析
Lancet. 2025 Oct 18;406(10513):1731-1810. doi: 10.1016/S0140-6736(25)01330-3. Epub 2025 Oct 12.
7
The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.1990-2023年全球、区域和国家癌症负担及到2050年的预测:全球疾病负担研究2023的系统分析
Lancet. 2025 Oct 11;406(10512):1565-1586. doi: 10.1016/S0140-6736(25)01635-6. Epub 2025 Sep 24.
8
Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球、区域和国家的卒中负担及其风险因素,1990-2021 年:2021 年全球疾病负担研究的系统分析。
Lancet Neurol. 2024 Oct;23(10):973-1003. doi: 10.1016/S1474-4422(24)00369-7.
9
Global, regional, and national burden of maternal disorders, 1990-2021: a systematic analysis from the global burden of disease study 2021.1990 - 2021年全球、区域和国家孕产妇疾病负担:全球疾病负担研究2021的系统分析
BMC Public Health. 2025 Jul 29;25(1):2576. doi: 10.1186/s12889-025-23814-w.
10
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险

引用本文的文献

1
Widening Racial and Sociodemographic Disparities in Cardiovascular Disease Death Counts in the United States: A Comprehensive Analysis of 2018-2023 National Data.美国心血管疾病死亡人数中日益扩大的种族和社会人口统计学差异:对2018 - 2023年国家数据的综合分析
Cureus. 2025 Oct 23;17(10):e95210. doi: 10.7759/cureus.95210. eCollection 2025 Oct.
2
The European Program for Prevention (EPP) - Implementing Proven Preventing Measures Now!欧洲预防计划(EPP)——立即实施经证实的预防措施!
Glob Heart. 2025 Nov 14;20(1):103. doi: 10.5334/gh.1491. eCollection 2025.
3
Bridging the Heart and Brain-Grand Challenges in the Diagnosis and Management of Cardiovascular and Cerebrovascular Diseases.
连接心脏与大脑——心血管和脑血管疾病诊断与管理中的重大挑战
Diagnostics (Basel). 2025 Oct 28;15(21):2726. doi: 10.3390/diagnostics15212726.
4
Prognostic significance of the CALLY index for cancer risk and survival: evidence from NHANES 2001-2018.CALLY指数对癌症风险和生存的预后意义:来自2001 - 2018年美国国家健康与营养检查调查(NHANES)的证据
World J Surg Oncol. 2025 Nov 11;23(1):431. doi: 10.1186/s12957-025-04094-5.
5
Comparative Analysis of Serum Lipid Profiles in Sanctuary-Housed Chimpanzees () at Tacugama Chimpanzee Sanctuary.塔库加马黑猩猩保护区内圈养黑猩猩的血脂谱比较分析
Vet Sci. 2025 Oct 13;12(10):985. doi: 10.3390/vetsci12100985.
6
Development and validation of a risk prediction algorithm for high-risk populations combining genetic and conventional risk factors of cardiovascular disease.结合心血管疾病遗传和传统风险因素的高危人群风险预测算法的开发与验证
PLoS One. 2025 Oct 21;20(10):e0335064. doi: 10.1371/journal.pone.0335064. eCollection 2025.